TITLE

Non-medical prescribing of chemotherapy: engaging stakeholders to maximise success?

AUTHOR(S)
Lennan, Elaine
PUB. DATE
June 2014
SOURCE
Ecancermedicalscience;2014, Vol. 8 Issue 413-446, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aim: This study report examines the views and experiences of professional stakeholders about non-medical prescribing (NMP) of chemotherapy. Background: The introduction of open formulary NMP has created opportunities to radically change health-care delivery. For chemotherapy services, the most recent advice from the National Chemotherapy Advisory Group [Department of Health (2009) Chemotherapy Services in England, ensuring quality and safety: a report from the National Chemotherapy Advisory Group, London Her Majesty's Stationary Office] clearly endorses the development of nurse- or pharmacist-led chemotherapy clinics. This is very much welcomed but is based on very limited evidence as to their effectiveness. Design: A fourth-generation evaluation study. Methods: A purposeful sample of 23 stakeholders connected with the chemotherapy service was used. A serial data collection technique with individual interviews followed by uni-professional focus groups was adopted. Finally, a multi-professional focus group was held to determine the strategic way forward. Data were collected in 2009-2010. Results: The study illuminated the key features necessary to maximise success of NMP in chemotherapy clinics and captures the importance of good working relationships. Whilst different practice models will emerge, fundamental and core to services is the need for good team working, established and effective communication strategies, and most importantly avoiding isolation in practice. This study additionally reinforced any evaluation takes place within preexisting political contexts and in particular medical dominance. Not all medical colleagues agreed with or wanted NMP for their patients, highlighting difficulties of developing new models of working within a resisting culture. Conclusion: No objections to NMP of chemotherapy were found, but, clearly, the context of practice needs to be agreed and supported by all professional stakeholders.
ACCESSION #
97255393

 

Related Articles

  • A novel tool to monitor adherence to oral oncolytics: a pilot study. Sun, Wendy; Reeve, Rebecca; Ouellette, Timothy; Stutsky, Martha; Jesus, Rachel De; Huffer, Michael J; Mougalian, Sarah Schellhorn // Journal of Drug Assessment;2019 Supplement 1, Vol. 8, p38 

    Background: Non-adherence is an important issue in cancer care as more oral cytotoxic and targeted agents become available. Although oral therapies may be more convenient for patients, measuring and optimizing adherence is challenging. The Nomi system records real-time medication taking behavior...

  • Independent Nurse: DoH backs wider prescribing powers for nurses. Lepper, Joe // GP: General Practitioner;10/14/2005, p92 

    The article states that English Department of Health (DoH) has for the first time publicly announced it is backing nurse prescriber calls for access to the full formulary. The move comes ahead of a meeting later this month when the independent Committee on Safety of Medicines will decide on...

  • Independent Nurse: Opinion - Exciting times ahead for nurse prescribing. Stuttle, Barbara // GP: General Practitioner;10/14/2005, p106 

    Focuses on recent developments related to nurse prescribing. Opinion of the English Department of Health on non-medical prescribers; Need for continuing professional development for nurses; Recognition of the skill, expertise and accountability required in undertaking prescribing.

  • Funding doubts threaten roll out of full prescribing.  // Nursing Standard;3/1/2006, Vol. 20 Issue 25, p7 

    The article reports on the lack of funding for the launch of the nurse prescribing program in England. Chief nursing officer Chris Beasley had a contention with the ministers when the government did not provide the required funding to affirm the policy. However, she claimed that the Department...

  • Neo-adjuvant chemo-radiation of rectal cancer with Volumetric Modulated Arc Therapy: summary of technical and dosimetric features and early clinical experience. Richetti, Antonella; Fogliata, Antonella; Clivio, Alessandro; Nicolini, Giorgia; Pesce, Gianfranco; Salati, Emanuela; Vanetti, Eugenio; Cozzi, Luca // Radiation Oncology;2010, Vol. 5, p14 

    Background: To report about initial technical and clinical experience in preoperative radiation treatment of rectal cancer with volumetric modulated arcs with the RapidArc® (RA) technology. Methods: Twenty-five consecutive patients (pts) were treated with RA. All showed locally advanced...

  • Oral chemotherapy prescription safety practices in Europe. Conde-Estévez, David; Albanell, Joan // International Journal of Clinical Pharmacy;Oct2014, Vol. 36 Issue 5, p863 

    The authors discuss safety practices of oral chemotherapy prescription in Europe. They cite surveys on oral chemotherapy prescription and describe the process of dispensing oral chemotherapy by community pharmacists or hospital pharmacists, along with the differences in their involvement. The...

  • Incidence of infusion-site reactions associated with peripheral intravenous administration of fosaprepitant. Lundberg, Jordan; Crawford, Brooke; Phillips, Gary; Berger, Michael; Wesolowski, Robert // Supportive Care in Cancer;Jun2014, Vol. 22 Issue 6, p1461 

    Purpose: Fosaprepitant is known to cause infusion-site reactions. However, there is limited data regarding these reactions including the effect of peripheral intravenous administration or other potential factors on their incidence. This single-institution retrospective study was undertaken to...

  • Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network. JE Lamb, Maxine; Roman, Eve; Howell, Debra A.; Kane, Eleanor; Bagguley, Timothy; Burton, Cathy; Patmore, Russell; Smith, Alexandra G. // BJGP Open;Dec2019, Vol. 3 Issue 4, p1 

    Background: Hodgkin lymphoma is usually detected in primary care with early signs and symptoms, and is highly treatable with standardised chemotherapy. However, late presentation is associated with poorer outcomes. Aim: To investigate the relationship between markers of advanced disease,...

  • Patients' views on their consultation experience in community pharmacies and the potential prescribing role for pharmacists in Nigeria. Auta, Asa; Fredrick, Nonso Chiobi; David, Shalkur; Banwat, Samuel Benjamin; Adeniyi, Michael Adebayo // Journal of Pharmaceutical Health Services Research;Dec2014, Vol. 5 Issue 4, p233 

    Objectives The study aims to explore the views of patients of community pharmacists on their consultation experiences, and the possible extension of prescribing rights to pharmacists in Nigeria. Method A questionnaire survey was conducted in April to May 2012 in Jos, Nigeria, among 432 patients...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics